Addex Therapeutics Ltd American Depositary Shares vs. NVIDIA Corporation
ADXN
Addex Therapeutics Ltd American Depositary Shares
$3.50 -0.85%
VS NVDANVIDIA Corporation
$228.87 +0.66%
Addex Therapeutics Ltd American Depositary Shares and NVIDIA Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ADXN | NVDA | |
|---|---|---|
| Market Cap | $4.43 million | $5.53 trillion |
| Revenue (TTM) | — | $302.97 billion |
| Net Income (TTM) | — | $192.88 billion |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| ADXN | NVDA | |
|---|---|---|
| P/E Ratio | — | 28.93 |
| Price / Book | — | 24.13 |
| Price / Sales | — | 18.24 |
ADXN and NVDA split the valuation factors evenly.
Profitability
| ADXN | NVDA | |
|---|---|---|
| Net Margin | — | 63.66% |
| Return on Equity | — | 84.23% |
ADXN and NVDA split the profitability factors evenly.
Dividend
| ADXN | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.44% |
| Payout Ratio | — | 12.64 |
ADXN and NVDA split the dividend factors evenly.
Risk & Sentiment
| ADXN | NVDA | |
|---|---|---|
| Short Interest | 0.06% | 0.07% |
ADXN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ADXN overview, ADXN financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.